M. Callander, S. Haghighi, A.-M. Landtblom, C.E. Ahlgren, S.I. Nilsson, L. Rydberg, H. Al Khoury, L. Rosengren, and O. Andersen

Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis
Mult Scler 2007 13: 441-445. [Abstract] [PDF] [References]  

A. Sidoti, C. Antognelli, C. Rinaldi, R. D'Angelo, V. Dattola, P. Girlanda, V. Talesa, and A. Amato

Glyoxalase I A111E, paraoxonase 1 Q192R and L55M polymorphisms: susceptibility factors of multiple sclerosis?
Mult Scler 2007 13: 446-453. [Abstract] [PDF] [References]  

D. Otaegui, A. Saenz, J. Ruiz-Martinez, J. Olaskoaga, and A. López de Munain

UCP2 and mitochondrial haplogroups as a multiple sclerosis risk factor
Mult Scler 2007 13: 454-458. [Abstract] [PDF] [References]  

K. Hamamcioglu and AT Reder

Interferon-ß regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis
Mult Scler 2007 13: 459-470. [Abstract] [PDF] [References]  

S. Lindquist, N. Bodammer, J. Kaufmann, F. König, H.-J. Heinze, W. Brück, and M. Sailer

Histopathology and serial, multimodal magnetic resonance imaging in a multiple sclerosis variant
Mult Scler 2007 13: 471-482. [Abstract] [PDF] [References]  

B. Audoin, G. Davies, W. Rashid, L. Fisniku, A.J. Thompson, and D.H. Miller

Voxel-based analysis of grey matter magnetization transfer ratio maps in early relapsing remitting multiple sclerosis
Mult Scler 2007 13: 483-489. [Abstract] [PDF] [References]  

R. Zivadinov, L. Locatelli, D. Cookfair, B. Srinivasaraghavan, A. Bertolotto, M. Ukmar, A. Bratina, C. Maggiore, A. Bosco, A. Grop, M. Catalan, and M. Zorzon

I nterferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy
Mult Scler 2007 13: 490-501. [Abstract] [PDF] [References]  

M. Rovaris, G. Comi, MA Rocca, P. Valsasina, D. Ladkani, E. Pieri, S. Weiss, G. Shifroni, JS Wolinsky, M. Filippi, and European/Canadian Glatiramer Acetate Study Group

Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial
Mult Scler 2007 13: 502-508. [Abstract] [PDF] [References]  

S. Schach, M. Scholz, J.S. Wolinsky, and L. Kappos

Pooled historical MRI data as a basis for research in multiple sclerosis - a statistical evaluation
Mult Scler 2007 13: 509-516. [Abstract] [PDF] [References]  

R.K. Zabad, L.M. Metz, T.R. Todoruk, Y. Zhang, J.R. Mitchell, M. Yeung, D.G. Patry, R.B. Bell, and V.W. Yong

The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study
Mult Scler 2007 13: 517-526. [Abstract] [PDF] [References]  

L. Miller, P. Mattison, L. Paul, and L. Wood

The effects of transcutaneous electrical nerve stimulation (TENS) on spasticity in multiple sclerosis
Mult Scler 2007 13: 527-533. [Abstract] [PDF] [References]  

LI Iezzoni and L. Ngo

Health, disability, and life insurance experiences of working-age persons with multiple sclerosis
Mult Scler 2007 13: 534-546. [Abstract] [PDF] [References]  

S.L. Minden, D. Frankel, L. Hadden, and D.C. Hoaglin

Access to health care for people with multiple sclerosis
Mult Scler 2007 13: 547-558. [Abstract] [PDF] [References]  

C.A. Deruaz, F. Spertini, F. Souza Lima, R.A. Du Pasquier, and M. Schluep

Anaphylactic reaction to methylprednisolone in multiple sclerosis: a practical approach to alternative corticosteroids
Mult Scler 2007 13: 559-560. [PDF] [References]  

E. Fainardi, M. Castellazzi, T. Bellini, and F. Dallocchio

Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies
Mult Scler 2007 13: 561-562. [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.